NEWS & BLOG
X-ZELL announces routine lab collaboration in Germany
Frankfurt, June 2023 – X-ZELL, a pioneering company in the field of next-generation cytology, is proud to announce a strategic collaboration with the Medizinisches Versorgungszentrum für Pathologie, Zytodiagnostik und Molekularpathologie (MVZ) in Frankfurt, Germany, a...
Former Roche Diagnostics NAM CEO joins X-ZELL executive board
Singapore, August 2022 – X-ZELL is proud to announce the appointment of Michael Tillmann as member of the company’s executive board. Drawing on more than 30 years of experience in the pharmaceutical and diagnostics industry, Mr Tillmann previously held the CEO...
X-ZELL launches new Imaging Technology unit
Singapore, August 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the formation of a new, interdisciplinary Imaging Technology division. The announcement comes on the back of a new collaboration agreement with Finnish Artificial Intelligence (AI)...
X-ZELL announces strategic expansion in Europe
Lennestadt, February 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the opening of a new international office in Germany. Recently voted the second-most innovative health-tech start-up in the world1, X-ZELL has developed a powerful platform...
MedTech Innovator names X-ZELL as 2020 Asia Pacific Final Competition Winner
Los Angeles & Singapore, November 2020 (via Business Wire) – MedTech Innovator, the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), today announced X-ZELL as the winner of its 2020...
X-ZELL named second-most innovative health tech start-up in the world
Singapore, November 2020 – X-ZELL placed second in a virtual referendum to determine the world’s most innovative health technology start-up. Fellow Singaporean start-up, Plano, took home the overall win after an eight-week voting process. Organised by global analyst...
World-first cancer screening technology trialled in Singapore
Singapore, November 2020 – Two of Singapore’s leading hospitals and medical research centres, National University Hospital (NUH) and Singapore General Hospital (SGH), are trialling a new diagnostic test capable of detecting traces of early-stage prostate cancer in a...
X-ZELL secures investment by German industrial services powerhouse, DIAG
Singapore/ Essen, October 2019 – German industrial services specialist, Deutsche Industrieanlagen (DIAG), has officially joined X-ZELL’s US$3m Seed+ funding round. Ranked amongst Asia’s 50 most innovative health technology start-ups for two years running, X-ZELL...
X-ZELL ranked among Top 50 health tech start-ups in Asia
Singapore, October 2019 – X-ZELL has been ranked amongst the 50 leading health tech start-ups in Asia for the second year running. Every year, the prestigious list is compiled by Singapore-based analytics and advisory firm, Galen Growth Asia, which has developed a...
X-ZELL Global HQ now open for business
Singapore, May 2019 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, today opened its new global headquarters at Paya Lebar Square in Singapore, conveniently located between Changi Airport and the city's vibrant Central Business...
X-ZELL Cryoimmunostaining™ Suite celebrates world premiere in Singapore
Singapore, February 2019 – Rare cell detection specialist X-ZELL is proud to announce the world premiere of the world’s first 8-channel multiplexing technology, Cryoimmunostaining™ . Originally designed to enable the company’s headline-making research into...